IRENEA – Instituto de Rehabilitación Neurológica

( Spain )

IRENEA, the Neurological Rehabilitation Institute of Vithas Hospitals, has been treating patients who have suffered brain injuries or other neurological disorders in adults and children, and neurodevelopmental disorders in children, for more than 25 years. Our aim is to provide specialised, adapted and interdisciplinary neurological rehabilitation that combines close personal treatment with the latest scientific and technological advances. 

IRENEA was founded at the end of 1998 at the Hospital Valencia al Mar (Valencia), the first brain injury centre in the Valencian Community and one of the first hospitals in Spain to admit patients with acquired brain injuries.

IRENEA currently has five centres in different locations in Spain: Valencia, Aguas Vivas, Elche, Seville and Vigo, where it offers early, intensive, multidisciplinary and individualised rehabilitation, with its own new technologies and innovative concepts in the field of neurorehabilitation, making them centres at the forefront in the field of care for brain injuries and rehabilitation of neurological diseases.

In addition, IRENEA has a specialised team that conducts research on the application of new technologies to improve the quality of care provided to its patients, which includes participating in national and international conferences, publishing research papers in scientific journals, collaborating in clinical trials, carrying out R&D projects and developing agreements with universities to help PhD students with their doctoral theses, among other actions.

Finally, and related to its eagerness to share quality knowledge, in this case for the caregiver, in 2014 it developed a mobile application with advice and suggestions to help with the care of patients with brain damage, with the aim of improving the entire environment of people who have suffered a stroke, traumatic brain injury, brain tumour, are in a vegetative state or state of minimal consciousness or suffer from neurodegenerative diseases such as Alzheimer’s, Lou Gehrig’s disease (ALS), Parkinson’s, dementia, Huntington’s disease, etc.

Today, with EarlyBrain, they aim to help children and their primary caregivers, as well as their immediate social environment, in equal parts, through the transfer of their knowledge in neurodevelopmental disorders.

Other partners

Translate »